SS

Shiva Shivaji Suryawanshi

Director Director DIN 08190474
DIN 08190474 First appointment Aug 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2018
Shareholding value •••• Premium profile

About Shiva Shivaji Suryawanshi

Data last updated:

Shiva Shivaji Suryawanshi was a Director at Dr Nigam's Goodhealth Private Limited (2018–2025) and Director at Anagen Clinics Private Limited (2018–2024). The companies operate in Healthcare.

DIN 08190474
Primary Designation Director
Industry Healthcare
First Appointment 02 Aug 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20182002₹83.1 Lakh (FY 2025)Active
Anagen Clinics Private Limited U85191MH2015PTC267926
Director02 Aug 20182015₹57.2 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dr Nigam's Goodhealth Private Limited
Anagen Clinics Private Limited
Premium access

Shareholding and investment profile for Shiva Shivaji Suryawanshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiva Shivaji Suryawanshi

Shiva Shivaji Suryawanshi was first appointed on 02 Aug 2018 as Director at Anagen Clinics Private Limited.

Shiva Shivaji Suryawanshi held 2 earlier board appointments: Dr Nigam's Goodhealth Private Limited (Director, 30 Sep 2018 to 02 Jan 2025); Anagen Clinics Private Limited (Director, 02 Aug 2018 to 02 Oct 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available